NUON's Shareholding in Telcon RF Pharmaceutical Drops 90% in 10:1 Reverse Stock Split, Ownership Unchanged at 19.20%

NUON, as the major and de facto controlling shareholder of Telcon RF Pharmaceutical, saw its shareholding drop from 13,736,493 to 1,373,649 shares due to a 10:1 reverse stock split effective June 6, 2026, but its ownership percentage remained unchanged at 19.20% as total shares were reduced proportionally.
The capital reduction is a share consolidation without dilution or capital increase, interpreted as a financial strategy to improve capital efficiency.
No separate fundraising or dividend policy changes were reported, and NUON's ownership structure remains intact.
[AI Summary]This filing reports a change in ownership due to a 10:1 reverse stock split, a neutral event for shareholder value. While trading liquidity may be affected post-consolidation, the underlying enterprise value is unchanged.